Lemer Pax Revenue and Competitors

La Chapelle-sur-erdre Cedex, FR

Location

N/A

Total Funding

Medical

Industry

Estimated Revenue & Valuation

  • Lemer Pax's estimated annual revenue is currently $60.9M per year.(i)
  • Lemer Pax's estimated revenue per employee is $419,972

Employee Data

  • Lemer Pax has 145 Employees.(i)
  • Lemer Pax grew their employee count by 22% last year.

Lemer Pax's People

NameTitleEmail/Phone
1
Responsable du contrôle de gestionReveal Email/Phone
2
Technicien ordonnancementReveal Email/Phone
3
Chef de projets / Responsable d'affaires Secteur IndustrieReveal Email/Phone
4
Ingénieure développement logicielReveal Email/Phone
5
Pilote équipe enceintesReveal Email/Phone
6
Purchasing Assistant - ProviderReveal Email/Phone
7
Référent support clientReveal Email/Phone
8
Technicien Ordonnancement MéthodesReveal Email/Phone
9
Assistance Administration des Ventes Service Support ClientReveal Email/Phone
10
Dessinateur projeteur mécaniqueReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$37.4M9820%N/AN/A
#2
$25.6M6722%N/AN/A
#3
$232.8M48924%N/AN/A
#4
$7.9M26100%$17.1MN/A
#5
$102.8M24523%N/AN/A
#6
$43.8M11522%N/AN/A
#7
$39.7M10422%N/AN/A
#8
$1.9M860%N/AN/A
#9
$3.3M1417%N/AN/A
#10
$60.9M14522%N/AN/A
Add Company

What Is Lemer Pax?

Partner of the CEA since it was founded, Lemer Pax designs and produces radiation protection equipment and shielded infusion systems for use in x-ray, interventional cardiology, radiology,and neurolgy and nuclear medicine applications, research, industry and nuclear protection. \n\nWith over 50 years of innovation, and supported by its scientific college of international experts, it has become the world leader in innovation in its sectors of activity, exporting its technologies throughout the world.\n\nLemer Pax is very actively involved in the optimization of the protection of operators exposed to ionizing radiation.

keywords:N/A

N/A

Total Funding

145

Number of Employees

$60.9M

Revenue (est)

22%

Employee Growth %

N/A

Valuation

N/A

Accelerator